substantia nigra And NotYves Agid
List of bibliographic references
Number of relevant bibliographic references: 5.Ident. | Authors (with country if any) | Title |
---|---|---|
000066 | David A. Price [États-Unis] ; Alex A. Martinez [États-Unis] ; Alexandre Seillier [États-Unis] ; Wouter Koek [États-Unis] ; Yolanda Acosta [États-Unis] ; Elizabeth Fernandez [États-Unis] ; Randy Strong [États-Unis] ; Beat Lutz [Allemagne] ; Giovanni Marsicano [France] ; James L. Roberts [États-Unis] ; Andrea Giuffrida [États-Unis] | WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease |
000096 | Andrew Lees (neurologue) [Royaume-Uni] ; Marianna Selikhova [Royaume-Uni] ; Luiz Augusto Andrade [Brésil] ; Charles Duyckaerts [France] | The black stuff and Konstantin Nikolaevich Tretiakoff |
000116 | Vincent Paillé [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
000184 | Yassine Darbaky [France] ; Claude Forni [France] ; Marianne Amalric [France] ; Christelle Baunez [France] | High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task |
000250 | Brigitte Piallat [France] ; Abdelhamid Benazzouz [France] ; Alim-Louis Benabid [France] | Subthalamic Nucleus Lesion in Rats Prevents Dopaminergic Nigral Neuron Degeneration After Striatal 6‐OHDA Injection: Behavioural and Immunohistochemical Studies |
This area was generated with Dilib version V0.6.23. |